Published guidance, NICE advice and quality standards | Guidance

Showing 21 to 30 of 911

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B	TA96	22 February 2006	22 February 2006
Afamelanotide for treating erythropoietic protoporphyria	HST27	26 July 2023	26 July 2023
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)	TA444	24 May 2017	24 May 2017
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer	TA310	23 April 2014	23 April 2014
Aflibercept for treating choroidal neovascularisation	TA486	1 November 2017	1 November 2017
Aflibercept for treating diabetic macular oedema	TA346	22 July 2015	22 July 2015
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion	TA409	28 September 2016	28 September 2016
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion	TA305	26 February 2014	26 February 2014
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	TA307	25 March 2014	25 March 2014